Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127876071 | 12787607 | 1 | I | 20160801 | 0 | 20160927 | 20160927 | DIR | US-FDA-351687 | FDA-CTU | 45.00 | YR | F | N | 47.25000 | KG | 20160927 | N | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127876071 | 12787607 | 1 | PS | CLINDAMYCIN | CLINDAMYCINCLINDAMYCIN PHOSPHATE | 1 | Oral | N | D | 0 | |||||||||
| 127876071 | 12787607 | 2 | C | VANCOMYCIN | VANCOMYCIN | 1 | 0 | ||||||||||||
| 127876071 | 12787607 | 4 | C | DIFLUCAN | FLUCONAZOLE | 1 | 0 | ||||||||||||
| 127876071 | 12787607 | 6 | C | DAILY MULTIVITAMIN | VITAMINS | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127876071 | 12787607 | 1 | Gingivitis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127876071 | 12787607 | DS |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127876071 | 12787607 | Clostridium difficile infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127876071 | 12787607 | 1 | 20160701 | 20160708 | 0 |